1. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, STPOST 07

    Consistency of bluTM e-cigarette nicotine delivery according to the AFNOR standard

    TSCHIERSKE N.(1); JULIEN R.(2); VARIGNON B.(2); TROUDE V.(2); DESTRUHAUT S.(2); WALELE T.(3); COLARD S.(2); CAHOURS X.(2)
    (1) Reemtsma Cigarettenfabriken GmbH (an Imperial Brands PLC Company), Hamburg, Germany; (2) SEITA-Imperial Tobacco Limited, Fleury-les-Aubrais, France; (3) Fontem Ventures B.V. (an Imperial Brands PLC Company), Amsterdam, The Netherlands
    Demonstrating the consistency of nicotine delivery from an e-cigarette is a requirement per EU Tobacco Product Directive (TPD) 2, Article 20, 3(f) (The European Council and the Council of the European Union, 2014). The Directive states that...
  2. CORESTA Congress, Berlin, 2016, Smoke Science/Product Technology Groups, STPOST 07

    Is a method to determine polycyclic aromatic hydrocarbons in cigarette smoke applicable to aerosols generated from heated tobacco products?

    GADOIS-POMMEREUL S.; BRU G.; PERROT R.; TROUDE V.
    SEITA-Imperial Tobacco, Fleury-les-Aubrais, France
    The market offers various new generation products, including heated tobacco products. In order to measure constituents in the aerosol of such products, methods developed for cigarette smoke were investigated for their applicability. This study is...
  3. CORESTA Congress, Quebec, 2014, Smoke Science/Product Technology Groups, STPOST 14

    Electronic devices – investigation of the direct thermal extraction properties of the e-liquid

    GADOIS-POMMEREUL S.; REY M.; LHERMITE S.; TROUDE V.
    Imperial Tobacco Group, SEITA, Fleury-les-Aubrais, France
    The mode of action of a wide range of e-devices on the market is based on the transfer of e-liquid compounds through a heated air flow. The aim of this work was to provide a method to assess the e-device for qualitative screening of the vapour...
  4. CORESTA Meeting, Smoke Science/Product Technology, 2013, Seville, STPOST 03

    Analytical method to model human mouth-level transfer of ingredients from Swedish pouched snus

    GRAPTON S. (1); GADOIS-POMMEREUL S.(1); TROUDE V.(1); BLANCHET M. (1); CLARKE A.(2); SIMMS L.(2)
    (1) SEITA, Imperial Tobacco Group, Fleury-les-Aubrais, France; (2) Imperial Tobacco Limited, Bristol, U.K.
    In parallel with the human study[1] a laboratory in vitro assay was conducted with three media: artificial saliva, water and 1% ß-cyclodextrin in water, using two snus products that were indistinguishable apart from the flavour application rate. To...